help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Croager, E. J.
Right arrow Articles by Abraham, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Croager, E. J.
Right arrow Articles by Abraham, L. J.
(American Journal of Pathology. 2000;156:1723-1731.)
© 2000 American Society for Investigative Pathology


Regular Articles

Involvement of Sp1 and Microsatellite Repressor Sequences in the Transcriptional Control of the Human CD30 Gene

Emma J. Croager, Alexander M. Gout and Lawrence J. Abraham

From the Department of Biochemistry, University of Western Australia, Nedlands, Australia

CD30, as a member of the tumor necrosis factor (TNF) receptor family, is expressed on the surface of activated lymphoid cells. CD30 overexpression is a characteristic of lymphoproliferative diseases such as Hodgkin’s/non-Hodgkin’s lymphomas, embryonal carcinoma, and a number of Th2-associated diseases. The CD30 gene has been mapped to a region of the murine genome that is involved in susceptibility to systemic lupus erythematosus. Functionally, CD30 may play a role in the deletion of autoreactive T cells. We were interested in determining the molecular nature of CD30 overexpression. Sequence comparison has revealed significant identity between the TATA-less human and murine CD30 promoters; they share a number of common consensus binding motifs. Transfection assays identified three regions of transcriptional importance; the region between position -1.2 kb and -336 bp, containing a CCAT microsatellite sequence, a conserved Sp1 site at positions -43 to -38, and a downstream promoter element (DPE) at positions +24 to +29. EMSA and DNase I footprinting showed specific DNA-protein interactions of the CD30 promoter with the Sp1 site and the CCAT repeat region. The DPE element was shown to be essential for start site selection. We conclude that the conserved Sp1 site at -43 to -38 is associated with maximum reporter gene activity, the DPE element is required for start site selection, and the CCAT tetranucleotide repeats act to repress transcription. We also have shown that the microsatellite is multiallelic, when we screened a random healthy population. Further studies are required to determine whether microsatellite instability in the repressor predisposes susceptible individuals to CD30 overexpression.





This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
W. Shi, W. Zhou, and D. Xu
Identifying cis-regulatory elements by statistical analysis and phylogenetic footprinting and analyzing their coexistence and related gene ontology
Physiol Genomics, November 14, 2007; 31(3): 374 - 384.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Y.-Y. Hsu, P. B. Johnston, K. A. Burke, and Y. Zhao
The Expression of CD30 in Anaplastic Large Cell Lymphoma Is Regulated by Nucleophosmin-Anaplastic Lymphoma Kinase-Mediated JunB Level in a Cell Type-Specific Manner.
Cancer Res., September 15, 2006; 66(18): 9002 - 9008.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Watanabe, M. Sasaki, K. Itoh, M. Higashihara, K. Umezawa, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie
JunB Induced by Constitutive CD30-Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Signaling Activates the CD30 Promoter in Anaplastic Large Cell Lymphoma and Reed-Sternberg Cells of Hodgkin Lymphoma
Cancer Res., September 1, 2005; 65(17): 7628 - 7634.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Franchina, M. E. Kadin, and L. J. Abraham
Polymorphism of the CD30 Promoter Microsatellite Repressive Element Is Associated with Development of Primary Cutaneous Lymphoproliferative Disorders
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1322 - 1325.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G.-P. Zhou, C. Wong, R. Su, S. C. Crable, K. P. Anderson, and P. G. Gallagher
Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element
Blood, June 1, 2004; 103(11): 4302 - 4309.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hewetson and B. S. Chilton
An Sp1-NF-Y/Progesterone Receptor DNA Binding-dependent Mechanism Regulates Progesterone-induced Transcriptional Activation of the Rabbit RUSH/SMARCA3 Gene
J. Biol. Chem., October 10, 2003; 278(41): 40177 - 40185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Watanabe, Y. Ogawa, K. Ito, M. Higashihara, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie
AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg Cells
Am. J. Pathol., August 1, 2003; 163(2): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. J. Woo, J. S. Dods, E. Susanto, D. Ulgiati, and L. J. Abraham
A Proteomics Approach for the Identification of DNA Binding Activities Observed in the Electrophoretic Mobility Shift Assay
Mol. Cell. Proteomics, June 1, 2002; 1(6): 472 - 478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Abrescia, E. De Gregorio, M. Frontini, R. Mantovani, and P. Di Nocera
A Novel Intragenic Sequence Enhances Initiator-dependent Transcription in Human Embryonic Kidney 293 Cells
J. Biol. Chem., May 24, 2002; 277(22): 19594 - 19599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. E. Kadin
Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease
Am. J. Pathol., May 1, 2000; 156(5): 1479 - 1484.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.